SOX9通过偏向性对称细胞分裂调控胃干细胞转化
该研究利用小鼠胃化生和癌症模型、类器官CRISPR/Cas9操作及患者组织免疫组化,发现致癌损伤使SOX9+祖细胞扩增,SOX9+SOX2+细胞可自我更新并分化为全部胃上皮细胞。靶向SOX9+SOX2+细胞可致侵袭性胃癌,敲除Sox9可减少对称细胞分裂并阻断Kras诱导的肿瘤发生;胃癌患者中SOX9高表达与复发和不良预后相关。
要点
- 致癌损伤导致小鼠胃内SOX9+祖细胞扩增,SOX9+细胞与SOX2+祖细胞重叠并包含可自我更新的干细胞。
- 靶向SOX9+SOX2+细胞可在新小鼠模型中导致侵袭性胃癌,Sox9缺失可减少对称细胞分裂并阻断Kras诱导的肿瘤发生。
- 胃癌患者中SOX9高表达与复发和不良预后相关。
核心结论
- SOX9标记胃干细胞并通过调控偏向性对称细胞分裂影响胃干细胞的恶性转化。
研究设计与样本
- 研究采用小鼠胃化生和癌症模型、单细胞RNA测序再分析、免疫染色、类器官CRISPR/Cas9操作、溴脱氧尿苷追踪实验及患者胃组织病理和免疫染色。
主要发现
- 致癌损伤导致小鼠胃内SOX9+祖细胞扩增,SOX9+胃上皮细胞与SOX2+祖细胞重叠并包含可自我更新和分化为全部胃上皮细胞的干细胞。
- 在新小鼠模型(Sox2-CreERT;Sox9-loxp(66)-rtTA-T2A-Flpo-IRES-loxp(71);Kras(Frt-STOP-Frt-G12D);P53R172H)中靶向SOX9+SOX2+细胞导致侵袭性胃癌。
- Sox9缺失阻碍胃祖细胞扩增并阻断Kras激活后的肿瘤形成;在Kras激活背景下Sox9缺失减少对称细胞分裂并减弱Kras依赖的干/祖细胞扩增。
- 胃癌类器官中Sox9缺失减少对称细胞分裂、类器官数量和类器官大小。
- 胃癌患者中SOX9高水平与复发和不良预后相关。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Transformation of stem/progenitor cells has been associated with tumorigenesis in multiple tissues, but stem cells in the stomach have been hard to localize. We therefore aimed to use a combination of several markers to better target oncogenes to gastric stem cells and understand their behavior in the initial stages of gastric tumorigenesis. METHODS: Mouse models of gastric metaplasia and cancer by targeting stem/progenitor cells were generated and analyzed with techniques including reanalysis of single-cell RNA sequencing and immunostaining. Gastric cancer cell organoids were genetically manipulated with clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) for functional studies. Cell division was determined by bromodeoxyuridine-chasing assay and the assessment of the orientation of the mitotic spindles. Gastric tissues from patients were examined by histopathology and immunostaining. RESULTS: Oncogenic insults lead to expansion of SOX9+ progenitor cells in the mouse stomach. Genetic lineage tracing and organoid culture studies show that SOX9+ gastric epithelial cells overlap with SOX2+ progenitors and include stem cells that can self-renew and differentiate to generate all gastric epithelial cells. Moreover, oncogenic targeting of SOX9+SOX2+ cells leads to invasive gastric cancer in our novel mouse model (Sox2-CreERT;Sox9-loxp(66)-rtTA-T2A-Flpo-IRES-loxp(71);Kras(Frt-STOP-Frt-G12D);P53R172H), which combines Cre-loxp and Flippase-Frt genetic recombination systems. Sox9 deletion impedes the expansion of gastric progenitor cells and blocks neoplasia after Kras activation. Although Sox9 is not required for maintaining tissue homeostasis where asymmetric division predominates, loss of Sox9 in the setting of Kras activation leads to reduced symmetric cell division and effectively attenuates the Kras-dependent expansion of stem/progenitor cells. Similarly, Sox9 deletion in gastric cancer organoids reduces symmetric cell division, organoid number, and organoid size. In patients with gastric cancer, high levels of SOX9 are associated with recurrence and poor prognosis. CONCLUSION: SOX9 marks gastric stem cells and modulates biased symmetric cell division, which appears to be required for the malignant transformation of gastric stem cells.
引用
- Chen Q, Weng K, Lin M, et al. SOX9 Modulates the Transformation of Gastric Stem Cells Through Biased Symmetric Cell Division. Gastroenterology. 2023. PMID: 36740200. doi:10.1053/j.gastro.2023.01.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。